{"id":"W3040096066","doi":"10.1158/1078-0432.ccr-19-3884","title":"Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Cancer Research UK; Exelixis","keywords":"Cabozantinib; Medicine; Placebo; Hepatocellular carcinoma; Internal medicine; Gastroenterology; Confidence interval; Alpha-fetoprotein; Oncology; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002846312,0.0008340926,0.002132838,0.0003245212,0.000300159,0.0009509342,0.0003933785,0.0008539777,0.001072712],"category_scores_gemma":[0.002812278,0.0003473806,0.001423512,0.0003974923,0.0006165571,0.0004157275,0.0002630033,0.00149292,0.0002061801],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006752901,"about_ca_system_score_gemma":0.0007998343,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008174197,"about_ca_topic_score_gemma":0.001249214,"domain_scores_codex":[0.9991035,0.0006126591,0.00005935675,0.00006740148,0.00008883133,0.00006820138],"domain_scores_gemma":[0.9985583,0.000436986,0.0005184878,0.00007509773,0.0001062064,0.0003049154],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9371958,0.004707682,0.01747113,0.0007391578,0.003315825,0.00007589279,0.00007686447,0.0005399185,0.004080634,0.00005761112,0.0005777949,0.03116175],"study_design_scores_gemma":[0.6213413,0.224234,0.1420742,0.0001544083,0.005224063,0.0002722057,0.00009146625,0.00245695,0.00198516,0.0002873844,0.001834648,0.00004428878],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9831703,0.01498368,0.0002082694,0.000449367,0.0001530448,0.000249635,0.0001844663,0.0000297701,0.000571333],"genre_scores_gemma":[0.9963866,0.002274547,0.0002376709,0.0002836998,0.0002095338,0.000161871,0.0001827185,0.000004335189,0.0002590191],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002846312,"threshold_uncertainty_score":0.01505291,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3616713562837686,"score_gpt":0.4810952114332623,"score_spread":0.1194238551494937,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}